Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,002 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical benefit of bone-targeted radiometabolic therapy with 153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer.
Ricci S, Boni G, Pastina I, Genovesi D, Cianci C, Chiacchio S, Orlandini C, Grosso M, Alsharif A, Chioni A, Di Donato S, Francesca F, Selli C, Rubello D, Mariani G. Ricci S, et al. Among authors: mariani g. Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):1023-30. doi: 10.1007/s00259-006-0343-8. Epub 2007 Jan 23. Eur J Nucl Med Mol Imaging. 2007. PMID: 17242920
Recombinant human TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer: the effect of pre-treatment with furosemide and furosemide plus lithium.
Barbaro D, Grosso M, Boni G, Lapi P, Pasquini C, Orsini P, Turco A, Meucci G, Marzola MC, Berti P, Miccoli P, Mariani G, Rubello D. Barbaro D, et al. Among authors: mariani g. Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):242-9. doi: 10.1007/s00259-009-1254-2. Epub 2009 Sep 4. Eur J Nucl Med Mol Imaging. 2010. PMID: 19760415 Clinical Trial.
Radionuclide therapy and integrated protocols for bone metastases.
Chiacchio S, Mazzarri S, Lorenzoni A, Nyakale N, Boni G, Borsò E, Alsharif A, Grosso M, Manca G, Greco C, Volterrani D, Mariani G. Chiacchio S, et al. Among authors: mariani g. Q J Nucl Med Mol Imaging. 2011 Aug;55(4):431-47. Q J Nucl Med Mol Imaging. 2011. PMID: 21738116 Review.
Comparison between remnant and red-marrow absorbed dose in thyroid cancer patients submitted to 131I ablative therapy after rh-TSH stimulation versus hypothyroidism induced by L-thyroxine withdrawal.
Vaiano A, Claudio Traino A, Boni G, Grosso M, Lazzeri P, Colato C, Davì MV, Francia G, Lazzeri M, Mariani G, Ferdeghini M. Vaiano A, et al. Among authors: mariani g. Nucl Med Commun. 2007 Mar;28(3):215-23. doi: 10.1097/MNM.0b013e328014a0f6. Nucl Med Commun. 2007. PMID: 17264781 Clinical Trial.
No evidence of chromosome damage in children and adolescents with differentiated thyroid carcinoma after receiving 131I radiometabolic therapy, as evaluated by micronucleus assay and microarray analysis.
Federico G, Boni G, Fabiani B, Fiore L, Lazzeri P, Massart F, Traino C, Verola C, Saggese G, Mariani G, Scarpato R. Federico G, et al. Among authors: mariani g. Eur J Nucl Med Mol Imaging. 2008 Nov;35(11):2113-21. doi: 10.1007/s00259-008-0867-1. Epub 2008 Jul 22. Eur J Nucl Med Mol Imaging. 2008. PMID: 18648806
1,002 results